|1.||Kokubun, Seiichiro: 1 article (03/2009)|
|2.||Shimoji, Koki: 1 article (03/2009)|
|3.||Fukuda, Satoru: 1 article (03/2009)|
|4.||Morita, Shigeho: 1 article (03/2009)|
|5.||Gamou, Sanae: 1 article (03/2009)|
|6.||Yunokawa, Seki: 1 article (03/2009)|
|7.||Sakamoto, Hidetoshi: 1 article (03/2009)|
|8.||Ogura, Mai: 1 article (03/2009)|
05/01/1989 - "These results suggest that ONO 3708, the antagonist of TXA2 receptor, has beneficial effects during endotoxin shock, at least in part by inhibiting platelet aggregation."
05/01/1989 - "Protective effects of ONO 3708, a new thromboxane A2 receptor antagonist, during experimental endotoxin shock."
09/01/1989 - "These results suggest that role of thromboxane A2 on the cardiovascular response during endotoxin shock is played only on pulmonary vascular changes, and ONO 3708 has a beneficial effect at least during the early phase of endotoxin shock."
09/01/1989 - "The effects of ONO 3708, a new thromboxane A2 receptor antagonist, on cardiovascular and airway responses, at an early phase during endotoxin shock were investigated in anesthetized dogs. "
09/01/1989 - "[The effects of ONO 3708, a new thromboxane receptor antagonist, on cardiovascular response during the early phases of endotoxin shock in anesthetized dogs]."
02/15/1996 - "In group III, ONO 3708 (10 mg/kg, intravenous) was given 5 min before ischemia. "
01/01/1995 - "ONO 3708 (200 micrograms/kg/min) was initiated 60 min before induction of ischemia and continued throughout the experiment. "
11/01/1994 - "Mongrel dogs weighing from 10 to 15 kg were divided into three groups: a control group, a group with induced liver ischemia and subsequent reperfusion, and a group that received ONO 3708 and then underwent induced liver ischemia and subsequent reperfusion. "
11/01/1994 - "In this study the effects of the thromboxane A2 receptor antagonist ONO 3708 on ischemia and subsequent reperfusion in the dog liver was evaluated. "
01/01/1995 - "Thromboxane A2 receptor antagonist (ONO 3708) protects from liver damage induced by cholestasis and ischemia-reperfusion."
|1.||Prostaglandin H2 Thromboxane A2 Receptors
|4.||Thromboxane Receptors (Thromboxane Receptor)
|5.||Thromboxane A2 (A2, Thromboxane)
|8.||prostaglandin endoperoxide receptor
|9.||Oleic Acid (Oleate)